Development of a HER1/CP2c dual-targeting biopharmaceutical for HER1-overexpressing head and neck cancer.

Saved in:
Bibliographic Details
Title: Development of a HER1/CP2c dual-targeting biopharmaceutical for HER1-overexpressing head and neck cancer.
Authors: Byun KT; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Cho J; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Kim B; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Lee I; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Kim EB; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Park D; Laboratory Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University, Chuncheon, 24341, Republic of Korea., Han SW; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Won HS; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea., Cheon SY; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea. Electronic address: sycheon14@kku.ac.kr., Kim CG; Department of Biotechnology and Research Institute for Biomedical and Health Science (RIBHS), College of Biomedical and Health Science, Konkuk University, Chungju, 27478, Republic of Korea. Electronic address: changil.kim@kku.ac.kr.
Source: Biomaterials advances [Biomater Adv] 2026 Jun; Vol. 183, pp. 214782. Date of Electronic Publication: 2026 Feb 18.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918383886206676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-9508 (Electronic) Linking ISSN: 27729508 NLM ISO Abbreviation: Biomater Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-9508
DOI:10.1016/j.bioadv.2026.214782